Community acquired Panton-Valentine Leukocidin (PVL) positive Methicilin Resistant Staphylococcal aureus cerebral abscess in an 11-month old boy: a case study. by Mutale, Wilbroad et al.
Mutale, W; Sahay, KM; Hartley, J; Thompson, D; Ratnasinghe, D;
Hudson, L; Hulse, E; Fellows, G (2014) Community acquired Panton-
Valentine Leukocidin (PVL) positive Methicilin Resistant Staphylo-
coccal aureus cerebral abscess in an 11-month old boy: a case study.
BMC Res Notes, 7. p. 862. ISSN 1756-0500 DOI: 10.1186/1756-
0500-7-862
Downloaded from: http://researchonline.lshtm.ac.uk/2030896/
DOI: 10.1186/1756-0500-7-862
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
CASE REPORT Open Access
Community acquired Panton-Valentine
Leukocidin (PVL) positive Methicilin Resistant
Staphylococcal aureus cerebral abscess in an
11-month old boy: a case study
Wilbroad Mutale1,3*, Keya M Sahay4, John Hartley2, Dominic Thompson2, Didi Ratnasinghe4, Lee Hudson2,
Eleanor Hulse4 and Greg Fellows2
Abstract
Background: Brain abscess are uncommon childhood infection. Brain abscess caused by Panton-Valentine Leukocidin
positive Community acquired Methicillin Resistant Staphylococcal aureus have never been reported in the
United Kingdom.
Case presentation: We report a case of a previously well 11-month old boy of Indian origin who developed a
parietal lobe abscess from PVL positive CA-MRSA.
Conclusion: This case is one of the few described cases of brain abscess caused by PVL CA-MRSA in children.
The unusual (insidious) presentation, the absence of a clear staphylococcal focus and the unexpected finding of
a CA-MRSA in this patient highlight the challenges of managing such cases in clinical settings and the potential
future risk to public health.
Keywords: Panton-Valentine Leukocidin, Staphylococcus aureus, Methicilin Resistant Staphylococcal aureus,
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Background
Brain abscess are an uncommon childhood infection [1,2],
but remain a serious and life-threatening disease despite
advances in diagnosis and management [1]. Early diagno-
sis based on clinical signs and symptoms, and appropriate
investigation is associated with a better prognosis. The
availability of modern neuro-imaging techniques has
improved diagnosis of many brain pathologies including
brain abscess [1,3]. The other important factor responsible
for improvement in outcomes in recent time has been ac-
cess to potent antibiotic for most of the organisms causing
brain abscesses [1,4].
The most common causes of brain abscess in children
are aerobic and anaerobic streptococci (60 to70% of cases)
followed by gram-negative anaerobic bacilli (20 to 40%).
Enterobacteriaceae make up 20 to 30%. Staphylococcus
aureus comprise less than 15% [1]. Community acquired
Methicilin Resistant Staphylococcal aureus (CA-MRSA)
brain abscess is very rare in children with less than 5 cases
reported in literature [1,5]. Panton-Valentine Leukocidin
(PVL) is a toxic substance produced by some strains of
Staphylococcus aureus which is associated with an in-
creased ability to cause disease [6-8]. We report a case
of a previously well 11-month old Indian boy who devel-
oped a parietal lobe abscess from PVL positive CA-MRSA.
Case presentation
A previously fit and well 11-month old Indian boy, initially
presented to his local hospital with a 2 week history of
intermittent fevers, increasing irritability and anorexia.
There was a 24-hour history of diarrhea and vomiting
prior to admission. Additionally there was a history of
foreign travel to India for 6-months, having returned to
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the United Kingdom (UK) one-month prior to this pres-
entation. Apart from being lethargic when febrile, he was
otherwise well, eating and drinking, and had no neuro-
logical deficits. Urine collected at that time grew E.coli. He
was kept for observation and commenced on oral Co-
amoxiclav before being discharged to complete a 7-day
course. At this time his C-reactive protein (CRP) was
24 mg/dl(normal range: 0–1.0), White Cell Count
(WCC) 25x103 (Normal range 4.5-103))(neutrophils 14)
and blood cultures were negative.
Two weeks later, he re-presented with symptoms of per-
sistent fever, irritability, diarrohea & vomiting and photo-
phobia, he was noted to have lost about 1 kg of his weight.
Repeat CRP was 83 with a serumWCC of 30. Examination
revealed a drowsy, listless ill child that was photophobic.
There was no neck stiffness or skin rash. There were no
abnormal neurological signs.
Lumbar puncture revealed a cerebral spinal fluid (CSF)
WCC of 328(90% polymorphs), CSF protein was 1.2 g/l
and glucose of 1.7 mmol/l compared to 7 mmol/l in the
blood. No organisms were seen. A provisional diagnosis of
partially treated meningitis was made and the child was
commenced on ceftriaxone. Quadruple anti-tuberculous
medication (rifampicin, ethambutol, isoniazid and pyrazi-
namide) was also instigated in view of the recent foreign
travel.
Because of persisting drowsiness a Computerized
Tomography (CT) brain was performed. This revealed a
large lobulated low attenuation mass centered over the
right occipito-parietal region with extensive surrounding
vasogenic oedema consistent with an intracerebral ab-
scess. The scan also revealed moderate midline shift and a
low density left parafalcine subdural effusion Figure 1.
The child was transferred for urgent neurosurgical treat-
ment. Forty-eight mls of pus were aspirated via an image
guided needle aspiration of the right parietal lesion, in
which gram positive cocci were seen. Vancomycin, amika-
cin and metronidazole were started, with the cefotaxime
and rifampicin. Post-operatively the child’s clinical condi-
tion improved.
PVL CA-MRSA was cultured from the brain abscess
sample. Antibiotic sensitivity testing showed that the bac-
teria was only resistant to Flucloxacillin, ciprofloxacin and
trimethoprim, sensitive to gentamicin, Amikacin, Erythro-
mycin, Fucidin, Tetracycline, Linezolid, Vancomycin and
Rifampicin. The CSF and blood cultures from the local
hospital also grew MRSA. With the quantiferon test nega-
tive for Tuberculosis, antitubercuous medication was
discontinued and the antibiotic regime was rationalized to
intravenous Rifampicin, Vancomycin and Linezolid. The
isolate was referred to the Staphylococcal Reference
Laboratory, Colindale, Public Health England and shown
to be PVL gene positive. Typing showed it was spa type
021 with repeat succession 15-12-16-02-16-02-25-17-24
which is associated with PVL-MRSA belonging to MLST
clonal complex 30 (so-called South-West Pacific clone) re-
ported in the SWP region. The nose and throat MRSA
screen, and subsequent surface screens, were all negative.
An MRI brain, performed 2 days after the needle aspir-
ation (Figure 2), showed considerable reduction in the size
of the parieto-occipital abscess with persistence of the par-
afalcine collection. Given the clinical improvement and
the established microbiological diagnosis no further sur-
gery was performed and antibiotics were continued.
However one-week after surgery MRI demonstrated pro-
gression of the parafalcine collection (Figure 3) necessitat-
ing a second neurosurgical procedure. The parafalcine
collection was drained through a right frontal craniotomy
Figure 4. The pus aspirated was still culture positive for
MRSA after extended broth enrichment.
After 6 weeks of antibiotic therapy Magnetic Resonance
Imaging (MRI) showed almost complete resolution of the
abscess and empyema. The diffusion sequences showed
persistent active infection (Figure 5) and as such the anti-
biotics were continued for a further 2 weeks and then
stopped. A final MRI (Figure 6) after 12 weeks (1 month
off antibiotics) revealed resolution of the right parieto-
occipital abscess and left parafalcine collection without
any diffusion MRI evidence of active infection. At this
time the child was very well, had no neurological defi-
cits and had been afebrile with a CRP <5 for a month.
The patient has remained well after 10 months of
follow-up.
Figure 1 Pre-operative contrast enhanced CT scan.
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Discussion
Staphylococcus. aureus is a major human pathogen, caus-
ing a wide range of disease in humans from simple skin
infection to overwhelming sepsis and death. Serious infec-
tions occur most often in the first year of life and above
the age of 65 years [7,8]. Whilst S. aureus is known to
cause infection of the central nervous system, it is most
frequently a post-operative or trauma related pathogen,
and it is a very rare pathogen in community-onset menin-
gitis or brain abscess [1,2,9]. The organism has a wide
range of virulence factors, including the Panton-Valentine
Leukocidin, the possession of which is reported to be as-
sociated especially with skin infection and necrotising
pneumonia [6,7,10,11], although its importance is not uni-
versally excepted [8]. In addition to the multiple virulence
factors, S. aureus may be resistant to the commonly used
class of antibiotics including meticillin (hence called
MRSA). While MRSA is classically associated with health
care associated (HCA) strains, it more recently has been
detected in strains arising in the community (Community
associated, CA-MRSA) [7,8]. Unlike HCA MRSA, CA-
MRSA is usually PVL positive [7,8]. Rapid spread of CA-
MRSA has been recognised in certain areas or commu-
nities e.g. a North American clone in USA, designated
USA300 or a south west Pacific strain, designated the
SWP clone. The SWP clone is a rare cause of infection in
the UK, with one outbreak only reported [7]. Brain abscess
caused by PVL CA-MRSA are very rare and only two
cases have been described in adults [12,13]. To our
knowledge this is the first brain abscess caused by PVL
CA-MRSA in an infant.
Intracranial microbial infection in children may occur
by direct extension from the middle ear, paranasal sinuses
or indirectly via the haematogenous route from dental or
cardiac origin. However, findings from our case did not
clearly point to these well known sources of brain infection.
There was no evidence of ear or nasal infection and the
patient had no history of skull trauma, surgery or osteo-
myelitis. This is in contrast to other reported cases of PVL
CA-MRSA brain abscess in adults which have shown
clearly source of brain inoculation [6,10,12,13]. Addition-
ally, there was no evidence of a primary cutaneous or other
S. aureus focus.
The patient had been in India for 6 months before
presenting and is most likely to have acquired the SWP
Figure 2 Initial post-op magnetic resonance imaging.
Figure 3 Magnetic resonance imaging 1 week after admission.
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CA-MRSA clone while abroad travelling. Although
community acquired MRSA is prevalent in the Indian
subcontinent due to widespread antibiotic use, there is
no routine policy in the UK to evaluate children for MRSA
after foreign travel to endemic countries [14,15], as there
is for other multiple antibiotic resistant organisms. In
cases such as ours, tuberculosis could be considered more
likely in such children and MRSA is not one of the major
public health risk for many children who frequently travel
between UK and India. This case presented with very
none specific symptoms and was treated together with
all other children in the hospital up to 3 weeks before
the diagnosis was made. Most general paediatric units
do not have a policy to screen children for MRSA, how-
ever, this case demonstrates it is clearly important to
have a high index of suspicion when dealing with chil-
dren with history of international travel who apparently
have no other risk factors.
The CT-scan was not performed until approximately
3 weeks after initial symptoms. This case demonstrates
that life threatening intracranial sepsis with mass lesions
can develop insidiously in the absence of focal neurological
deficits or significantly impaired level of consciousness.
More evidence is required to guide policy and manage-
ment of similar cases.
Immunological evaluations including HIV tests showed
that the child had normal immunity and the parents re-
ported no health issues. In line with national policy for
management of PVL-MRSA this child and the family were
referred to Public Health for further management [8].
Figure 4 Magnetic resonance 2 weeks after admission & 1 week post 2nd operation.
Figure 5 Magnetic Resonance Imaging 6 weeks after admission.
Mutale et al. BMC Research Notes 2014, 7:862 Page 4 of 6
http://www.biomedcentral.com/1756-0500/7/862
Topical decolonisation was given, although this child had
not screened positive on surface swabs. In view of the
intracranial location of the infection (with poor vanco-
mycin penetration), and PVL positivity (experience with
necrotising pneumonia and PVL infection suggests use of
drugs that may reduce toxin production should be used),
therapy was initially continued with vancomycin, linezolid
and rifampicin. As the second aspirate, after 8 days of
good anti-MRSA therapy was still culture positive, he was
further continued on all 3 agents until the 6 week review.
There are a number of neurosurgical strategies that are
recommended for the treatment of brain abscess or empy-
ema ranging from simple aspiration through to craniot-
omy and excision of the abscess. The guiding principles of
management are to establish an accurate microbiological
diagnosis and to reduce mass effect. As demonstrated in
this case, it is not uncommon to require more than one
surgical intervention in the course of treatment. There
is some evidence to suggest that more minimalist proce-
dures are equally effective in treatment of intracranial
sepsis. Furthermore some have begun to suggest that
antibiotic courses could also be reduced, but we did not
do so here, extending the treatment longer because of
the slow resolution.
Conclusion
This case is one of the few described cases of brain abscess
caused by PVL CA-MRSA in children. There was no
evidence of ear or nasal infection and the patient had
no history of skull trauma, surgery or osteomyelitis. The
unusual (insidious) presentation, the absence of a clear
staphylococcal focus and the unexpected finding of a
CA-MRSA in this patient highlight the challenges of
managing such cases in clinical settings and the potential
future risk to public health from these virulent pathogens
associated with travel.
Consent
Written informed consent was obtained from the patient’s
parents for publication of this Case report and any accom-
panying images. A copy of the written consent is available
for review by the Editor of this journal.
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